PENERAPAN MODEL PEMBELAJARAN PICTURE AND PICTURE UNTUK MENINGKATKAN HASIL BELAJAR TENTANG SIKLUS AIR SISWA KELAS V UPT SD NEGERI 79 PINRANG

This research was motivated by the low learning achievement of science content students in class V UPT SD Negen 79 Pinrang. This research used a qualitative approach with a class action research type. The research subjects a teacher and were 20 students of grade V UPT SD Negeri 79 Pinrang. This research focused on the process and student learning achievement about the water cycle by applying the picture and picture. Data collected through observation, testing and documentation techniques while the data analysis techniques used were data collection, data reduction, data display and conclusion. This research was conducted in three cycles. The results of this research incated that cycle I the learning process of the teacher’s activities show sufficient qualifications (C), activities and student evaluation test show less qualification (K). Cycle II the teacher’s activity learning process show good qualification (B), activities and student evaluation test show sufficient qualification (C). Cycle III process and learning achievement are increasing with good qualifications (B). Therefore, it was concluded that by applying the picture and picture learning model it could improve the process and student achievement about the water cycle in class V UPT SD Negeri 79 Pinrang

PENERAPAN MODEL PEMBELAJARAN PICTURE AND PICTURE UNTUK MENINGKATKAN HASIL BELAJAR TENTANG SIKLUS AIR SISWA KELAS V UPT SD NEGERI 79 PINRANG

This research was motivated by the low learning achievement of science content students in class V UPT SD Negen 79 Pinrang. This research used a qualitative approach with a class action research type. The research subjects a teacher and were 20 students of grade V UPT SD Negeri 79 Pinrang. This research focused on the process and student learning achievement about the water cycle by applying the picture and picture. Data collected through observation, testing and documentation techniques while the data analysis techniques used were data collection, data reduction, data display and conclusion. This research was conducted in three cycles. The results of this research incated that cycle I the learning process of the teacher’s activities show sufficient qualifications (C), activities and student evaluation test show less qualification (K). Cycle II the teacher’s activity learning process show good qualification (B), activities and student evaluation test show sufficient qualification (C). Cycle III process and learning achievement are increasing with good qualifications (B). Therefore, it was concluded that by applying the picture and picture learning model it could improve the process and student achievement about the water cycle in class V UPT SD Negeri 79 Pinrang

Digital Twin and Blockchain Extension in Smart Buildings Platform as Cyber-Physical Systems

Cyber-physical systems is integrated computation with the physical world. CPS increasing in a wide range of applications, from smart homes to smart buildings. Digital twins are promising way to solve challenges with combination of CPS, 3D technology, and IoT. The system provides users with immersive interfaces to control and interact with devices within the smart building environment. Blockchain was chosen to secure user data using cryptographic algorithms and ensure data protection against manipulation, spying, and theft. Average load testing data for digital twin platform implemented in smart buildings range from 1 to 11 floors. The results reveal a gradual increase in average test times as the buildings' size and complexity grow, with the following values: 5.663s for 1 floor until 11 floors 7.294s. The data obtained from of the blockchain test using Hyperledger Besu provide essential insights into the system's performance with several bandwidth that used in the system. Average time for each test trial ranged from 1.066 seconds to 2.006 seconds, showing slight variations based on the bandwidth used. However, transactions per second (TPS) values were relatively fast, ranging from 1.066 tps to 0.499 tps with positive aspect of the retention rate for all trials was 100% success

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Background Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features modify the effects of antiplatelet therapy

Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: multispecialty, prospective cohort study in 25 countries

Background: Balancing opioid stewardship and the need for adequate analgesia following discharge after surgery is challenging. This study aimed to compare the outcomes for patients discharged with opioid versus opioid-free analgesia after common surgical procedures.Methods: This international, multicentre, prospective cohort study collected data from patients undergoing common acute and elective general surgical, urological, gynaecological, and orthopaedic procedures. The primary outcomes were patient-reported time in severe pain measured on a numerical analogue scale from 0 to 100% and patient-reported satisfaction with pain relief during the first week following discharge. Data were collected by in-hospital chart review and patient telephone interview 1 week after discharge.Results: The study recruited 4273 patients from 144 centres in 25 countries; 1311 patients (30.7%) were prescribed opioid analgesia at discharge. Patients reported being in severe pain for 10 (i.q.r. 1-30)% of the first week after discharge and rated satisfaction with analgesia as 90 (i.q.r. 80-100) of 100. After adjustment for confounders, opioid analgesia on discharge was independently associated with increased pain severity (risk ratio 1.52, 95% c.i. 1.31 to 1.76; P < 0.001) and re-presentation to healthcare providers owing to side-effects of medication (OR 2.38, 95% c.i. 1.36 to 4.17; P = 0.004), but not with satisfaction with analgesia (beta coefficient 0.92, 95% c.i. -1.52 to 3.36; P = 0.468) compared with opioid-free analgesia. Although opioid prescribing varied greatly between high-income and low- and middle-income countries, patient-reported outcomes did not.Conclusion: Opioid analgesia prescription on surgical discharge is associated with a higher risk of re-presentation owing to side-effects of medication and increased patient-reported pain, but not with changes in patient-reported satisfaction. Opioid-free discharge analgesia should be adopted routinely

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Background: Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial haemorrhage. Patients surviving the commonest subtype of intracranial haemorrhage, intracerebral haemorrhage, are at risk of both haemorrhagic and occlusive vascular events, but whether antiplatelet therapy can be used safely is unclear. We aimed to estimate the relative and absolute effects of antiplatelet therapy on recurrent intracerebral haemorrhage and whether this risk might exceed any reduction of occlusive vascular events. Methods: The REstart or STop Antithrombotics Randomised Trial (RESTART) was a prospective, randomised, open-label, blinded endpoint, parallel-group trial at 122 hospitals in the UK. We recruited adults (≥18 years) who were taking antithrombotic (antiplatelet or anticoagulant) therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage, discontinued antithrombotic therapy, and survived for 24 h. Computerised randomisation incorporating minimisation allocated participants (1:1) to start or avoid antiplatelet therapy. We followed participants for the primary outcome (recurrent symptomatic intracerebral haemorrhage) for up to 5 years. We analysed data from all randomised participants using Cox proportional hazards regression, adjusted for minimisation covariates. This trial is registered with ISRCTN (number ISRCTN71907627). Findings: Between May 22, 2013, and May 31, 2018, 537 participants were recruited a median of 76 days (IQR 29–146) after intracerebral haemorrhage onset: 268 were assigned to start and 269 (one withdrew) to avoid antiplatelet therapy. Participants were followed for a median of 2·0 years (IQR [1·0– 3·0]; completeness 99·3%). 12 (4%) of 268 participants allocated to antiplatelet therapy had recurrence of intracerebral haemorrhage compared with 23 (9%) of 268 participants allocated to avoid antiplatelet therapy (adjusted hazard ratio 0·51 [95% CI 0·25–1·03]; p=0·060). 18 (7%) participants allocated to antiplatelet therapy experienced major haemorrhagic events compared with 25 (9%) participants allocated to avoid antiplatelet therapy (0·71 [0·39–1·30]; p=0·27), and 39 [15%] participants allocated to antiplatelet therapy had major occlusive vascular events compared with 38 [14%] allocated to avoid antiplatelet therapy (1·02 [0·65–1·60]; p=0·92). Interpretation: These results exclude all but a very modest increase in the risk of recurrent intracerebral haemorrhage with antiplatelet therapy for patients on antithrombotic therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage. The risk of recurrent intracerebral haemorrhage is probably too small to exceed the established benefits of antiplatelet therapy for secondary prevention

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Background: Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial haemorrhage. Patients surviving the commonest subtype of intracranial haemorrhage, intracerebral haemorrhage, are at risk of both haemorrhagic and occlusive vascular events, but whether antiplatelet therapy can be used safely is unclear. We aimed to estimate the relative and absolute effects of antiplatelet therapy on recurrent intracerebral haemorrhage and whether this risk might exceed any reduction of occlusive vascular events. Methods: The REstart or STop Antithrombotics Randomised Trial (RESTART) was a prospective, randomised, open-label, blinded endpoint, parallel-group trial at 122 hospitals in the UK. We recruited adults (≥18 years) who were taking antithrombotic (antiplatelet or anticoagulant) therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage, discontinued antithrombotic therapy, and survived for 24 h. Computerised randomisation incorporating minimisation allocated participants (1:1) to start or avoid antiplatelet therapy. We followed participants for the primary outcome (recurrent symptomatic intracerebral haemorrhage) for up to 5 years. We analysed data from all randomised participants using Cox proportional hazards regression, adjusted for minimisation covariates. This trial is registered with ISRCTN (number ISRCTN71907627). Findings: Between May 22, 2013, and May 31, 2018, 537 participants were recruited a median of 76 days (IQR 29–146) after intracerebral haemorrhage onset: 268 were assigned to start and 269 (one withdrew) to avoid antiplatelet therapy. Participants were followed for a median of 2·0 years (IQR [1·0– 3·0]; completeness 99·3%). 12 (4%) of 268 participants allocated to antiplatelet therapy had recurrence of intracerebral haemorrhage compared with 23 (9%) of 268 participants allocated to avoid antiplatelet therapy (adjusted hazard ratio 0·51 [95% CI 0·25–1·03]; p=0·060). 18 (7%) participants allocated to antiplatelet therapy experienced major haemorrhagic events compared with 25 (9%) participants allocated to avoid antiplatelet therapy (0·71 [0·39–1·30]; p=0·27), and 39 [15%] participants allocated to antiplatelet therapy had major occlusive vascular events compared with 38 [14%] allocated to avoid antiplatelet therapy (1·02 [0·65–1·60]; p=0·92). Interpretation: These results exclude all but a very modest increase in the risk of recurrent intracerebral haemorrhage with antiplatelet therapy for patients on antithrombotic therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage. The risk of recurrent intracerebral haemorrhage is probably too small to exceed the established benefits of antiplatelet therapy for secondary prevention

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

BACKGROUND: Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial haemorrhage. Patients surviving the commonest subtype of intracranial haemorrhage, intracerebral haemorrhage, are at risk of both haemorrhagic and occlusive vascular events, but whether antiplatelet therapy can be used safely is unclear. We aimed to estimate the relative and absolute effects of antiplatelet therapy on recurrent intracerebral haemorrhage and whether this risk might exceed any reduction of occlusive vascular events. METHODS: The REstart or STop Antithrombotics Randomised Trial (RESTART) was a prospective, randomised, open-label, blinded endpoint, parallel-group trial at 122 hospitals in the UK. We recruited adults (≥18 years) who were taking antithrombotic (antiplatelet or anticoagulant) therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage, discontinued antithrombotic therapy, and survived for 24 h. Computerised randomisation incorporating minimisation allocated participants (1:1) to start or avoid antiplatelet therapy. We followed participants for the primary outcome (recurrent symptomatic intracerebral haemorrhage) for up to 5 years. We analysed data from all randomised participants using Cox proportional hazards regression, adjusted for minimisation covariates. This trial is registered with ISRCTN (number ISRCTN71907627). FINDINGS: Between May 22, 2013, and May 31, 2018, 537 participants were recruited a median of 76 days (IQR 29-146) after intracerebral haemorrhage onset: 268 were assigned to start and 269 (one withdrew) to avoid antiplatelet therapy. Participants were followed for a median of 2·0 years (IQR [1·0- 3·0]; completeness 99·3%). 12 (4%) of 268 participants allocated to antiplatelet therapy had recurrence of intracerebral haemorrhage compared with 23 (9%) of 268 participants allocated to avoid antiplatelet therapy (adjusted hazard ratio 0·51 [95% CI 0·25-1·03]; p=0·060). 18 (7%) participants allocated to antiplatelet therapy experienced major haemorrhagic events compared with 25 (9%) participants allocated to avoid antiplatelet therapy (0·71 [0·39-1·30]; p=0·27), and 39 [15%] participants allocated to antiplatelet therapy had major occlusive vascular events compared with 38 [14%] allocated to avoid antiplatelet therapy (1·02 [0·65-1·60]; p=0·92). INTERPRETATION: These results exclude all but a very modest increase in the risk of recurrent intracerebral haemorrhage with antiplatelet therapy for patients on antithrombotic therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage. The risk of recurrent intracerebral haemorrhage is probably too small to exceed the established benefits of antiplatelet therapy for secondary prevention. FUNDING: British Heart Foundation

Implementation Internet of Things Using Linear Regression Method For Supply Chain Management System

The Indonesian ministry of the industry stated that the development of industry must be a formidable industrial country in the world by 2025 and has carbon neutrality by 2060. This goal must be considered related to the distance of the supplier location from the industrial and it increases the gas emissions in the air. In this research, the proposed a solution for optimizing the delivery of material supplies from suppliers to the industry. The protocol communication uses the MQTT protocol to connect the device with a broker. This system will collect the information from sensors such as DHT 11, MQ-05, RFID, and other sensors to record the data, track the location, and validate the person accessing the goods and the data in a document. The data can be used as decision-making material using the regression linear method specifically at humidity and temperature. This device will connect to the user's smartphone by using an application that is connected by an online MQTT broker and see the condition of the goods, track the location of the delivery, and control the device from anywhere. The experiment result shows that the device can monitor temperature, humidity, CO2, LPG gas, and smoke gas. It also used the linear regression method used for determine the impact of the correlation between temperature and humidity at supply storage. The model summary states that the slope (B1) value is -1.8637 with a constant (B0) of 110.1554. B1 has a negative value. So, it can be concluded that the temperature variable negatively correlates with humidity. This method will be useful for the system to do some action to stabilize the condition inside the supply room such as giving a notification to the driver or turning on several pieces of equipment automatically to recover the condition. The proposed system is an IoT system using the openHAB platform as a UI that will be used in this system with a linear regression method to find the relationship between system parameters

Survey and Mapping Practicum Report

82 HalamanPada dasarnya alat ini berupa sebuah teleskop yang ditempatkan pada suatu dasar berbentuk membulat (piringan) yang dapat di putar mengelilingi sumbu vertikal, sehingga sudut horisontal untuk dibaca. Teleskop tersebut juga dipasang pada piringan keduadan dapat di putar putar mengelilingi sumbu horisontal, sehingga memungkinkan sudut vertikal untuk dibaca, kedua sudut tersebut dapat dibaca dengan tingkat ketelitian sangat tinggi (farrington 1997). Basically this tool is a telescope that is placed on a rounded base (disk) that can be rotated around the vertical axis, so that the horizontal angle is read. The telescope is also mounted on a second disk and can be rotated around the horizontal axis, allowing vertical angles to be read, both angles can be read with a very high level of accuracy (Farrington 1997)